NGS Sample Preparation MarketNGS Sample PreparationMarketwas valued at USD 1.54 Billion in 2021 and is projected to reach USD 4.32 Billion by 2028, growing at a Compound Annual Growth Rate (CAGR) of 15.1% during 2022-2028. NGS is a new technology that authorizes human genetic sequences overnight. It has a high sequence speed and improved expansion, resulting in better applications for research and development. NGS finds its use in the treatment of genetic disorders and clinical diagnosis.
Ongoing innovations made in the field of NGS Sample Preparation have led to standard sample preparation agreements that enhance the growth of the NGS Sample Preparation Market. The automation in the NGS Sample Preparation Market has resulted in participants using robotic instruments reducing costs and increasing exit from lab settings. Increasing demand for personalized treatment enhances the growth of the NGS Sample Preparation 10;Also, the increase in healthcare costs and advances in healthcare technology are factors that encourage growth of the NGS Sample Preparation Market. The use of NGS in the diagnosis of diseases such as cancer, diabetes, and treatment of other diseases is leading to market growth. The increase in big data creation has led to problems such as tracking and data management, which have been solved with the help of digital solutions such as NGS samples. NGS-based metagenomic experiments have also led to advances in the field of veterinary 10;However, there is a lack of agreements tailored to the needs of the animals, which affect the growth of the NGS Sample Preparation Market. Therefore, companies are developing NGS-based protocols that can be used in animal virology. The high costs associated with NGS sample preparation equipment, the lack of advanced genetic testing platforms, and strict NGS sample preparation rules are some of the key constraints expected to hamper market growth over the forecast period.
Based on the type of product, part of the NGS workstations is expected to experience rapid revenue growth during the forecast period due to factors such as reduced operating time and access to increased planning. The other part of this segment consists of reagents & consumables. On a technological basis, the market includes sequencing by synthesis (SBS), ion semiconductor sequencing, single-molecule real-time (SMRT) sequencing, nanopore sequencing. Based on end-use, part of educational institutions and research institutes are expected to control some of the end-of-life segments throughout the forecast period due to the high investment of market players and government support for genomics research. This leaves end users like hospitals & clinics, pharmaceutical & biotechnology companies among other end users in the segment.
NGS Sample Preparation Markethas been studied in North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.North America has the largest share of revenue in the global market by 2021 and is expected to maintain its top position during the forecast period due to the succession of the next generation, higher adoption of personal drugs, and the presence of major market players. The market is expected to register the fastest CAGR in the forecast period due to factors such as increased awareness of accurate medicine and increased funding from the private and public sectors.
Biocompare - a provider of health science products and new technologies, is committed to adding robotic tools to its sequencing processes to enable automated saving processes. In addition to medical services, companies in the NGS Sample Preparation Market are taking advantage of growing opportunities in the fields of agriculture and animal research to expand their sources of revenue.
Some major key players in the Global NGS Sample Preparation Market include Illumina Inc. (US), Agilent Technologies Inc. (US), Thermo Fisher Scientific Inc. (US), PerkinElmer Inc. (US), Roche AG (Switzerland) are the major companies operating in Global NGS Sample Preparation Market..
May 10, 2024
